Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

From first to second wave: follow-up of the prospective Covid-19 cohort (KoCo19) in Munich (Germany)

Katja Radon, Abhishek Bakuli, Peter Pütz, Ronan Le Gleut, Jessica Michelle Guggenbuehl Noller, Laura Olbrich, Elmar Saathoff, View ORCID ProfileMercè Garí, Yannik Schälte, Turid Frahnow, Roman Wölfel, Michael Pritsch, Camilla Rothe, Michel Pletschette, Raquel Rubio-Acero, Jessica Beyerl, Dafni Metaxa, Felix Forster, Verena Thiel, Noemi Castelletti, Friedrich Rieß, Maximilian N. Diefenbach, Günter Fröschl, Jan Bruger, Simon Winter, Jonathan Frese, Kerstin Puchinger, Isabel Brand, Inge Kroidl, Andreas Wieser, Michael Hoelscher, View ORCID ProfileJan Hasenauer, Christiane Fuchs on behalf of the KoCo19 study group
doi: https://doi.org/10.1101/2021.04.27.21256133
Katja Radon
1Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University Hospital, LMU Munich, 80336 Munich, Germany
2Center for International Health (CIH), University Hospital, LMU Munich, 80336 Munich, Germany
3Comprehensive Pneumology Center (CPC) Munich, German Center for Lung Research (DZL), 89337 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abhishek Bakuli
4Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Pütz
5Institute of Computational Biology, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany
6Faculty of Business Administration and Economics, Bielefeld University, 33615 Bielefeld, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronan Le Gleut
5Institute of Computational Biology, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany
7Core Facility Statistical Consulting, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica Michelle Guggenbuehl Noller
4Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Olbrich
4Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
8German Center for Infection Research (DZIF), partner site Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elmar Saathoff
4Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
8German Center for Infection Research (DZIF), partner site Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mercè Garí
5Institute of Computational Biology, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mercè Garí
Yannik Schälte
5Institute of Computational Biology, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany
9Center for Mathematics, Technische Universität München, 85748 Garching, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Turid Frahnow
5Institute of Computational Biology, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany
6Faculty of Business Administration and Economics, Bielefeld University, 33615 Bielefeld, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roman Wölfel
8German Center for Infection Research (DZIF), partner site Munich, Germany
10Bundeswehr Institute of Microbiology, 80937 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Pritsch
4Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
8German Center for Infection Research (DZIF), partner site Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Camilla Rothe
4Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel Pletschette
4Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raquel Rubio-Acero
4Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica Beyerl
4Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dafni Metaxa
4Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Felix Forster
1Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University Hospital, LMU Munich, 80336 Munich, Germany
3Comprehensive Pneumology Center (CPC) Munich, German Center for Lung Research (DZL), 89337 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Verena Thiel
4Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noemi Castelletti
4Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Friedrich Rieß
4Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
8German Center for Infection Research (DZIF), partner site Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maximilian N. Diefenbach
4Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Günter Fröschl
2Center for International Health (CIH), University Hospital, LMU Munich, 80336 Munich, Germany
4Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Bruger
4Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon Winter
4Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan Frese
4Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kerstin Puchinger
4Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabel Brand
4Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Inge Kroidl
4Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
8German Center for Infection Research (DZIF), partner site Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Wieser
4Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
8German Center for Infection Research (DZIF), partner site Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Hoelscher
2Center for International Health (CIH), University Hospital, LMU Munich, 80336 Munich, Germany
4Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany
8German Center for Infection Research (DZIF), partner site Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hoelscher@lrz.uni-muenchen.de
Jan Hasenauer
5Institute of Computational Biology, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany
9Center for Mathematics, Technische Universität München, 85748 Garching, Germany
11Interdisciplinary Research Unit Mathematics and Life Sciences, University of Bonn, 53113 Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jan Hasenauer
Christiane Fuchs
5Institute of Computational Biology, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany
6Faculty of Business Administration and Economics, Bielefeld University, 33615 Bielefeld, Germany
7Core Facility Statistical Consulting, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany
9Center for Mathematics, Technische Universität München, 85748 Garching, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background In the 2nd year of the Covid-19 pandemic, knowledge about the dynamics of the infection in the general population is still limited. Such information is essential for health planners, as many of those infected show no or only mild symptoms and thus, escape the surveillance system. We therefore aimed to describe the course of the pandemic in the Munich general population living in private households from April 2020 to January 2021.

Methods The KoCo19 baseline study took place from April to June 2020 including 5313 participants (age 14 years and above). From November 2020 to January 2021, we could again measure SARS-CoV-2 antibody status in 4,433 of the baseline participants (response 83%). Participants were offered a self-sampling kit to take a capillary blood sample (dry blood spot; DBS). Blood was analysed using the Elecsys® Anti-SARS-CoV-2 assay (Roche). Questionnaire information on socio-demographics and potential risk factors assessed at baseline was available for all participants. In addition, follow-up information on health-risk taking behaviour and number of personal contacts outside the household (N=2768) as well as leisure time activities (N=1263) were collected in summer 2020.

Results Weighted and adjusted (for specificity and sensitivity) SARS-CoV-2 sero-prevalence at follow-up was 3.6% (95% CI 2.9-4.3%) as compared to 1.8% (95% CI 1.3-3.4%) at baseline. 91% of those tested positive at baseline were also antibody-positive at follow-up. While sero-prevalence increased from early November 2021 to January 2021, no indication of geospatial clustering across the city of Munich was found, although cases clustered within households. Taking baseline result and time to follow-up into account, men and participants in the age group 20-34 years were at the highest risk of sero-positivity. In the sensitivity analyses, differences in health-risk taking behaviour, number of personal contacts and leisure time activities partly explained these differences.

Conclusion The number of citizens in Munich with SARS-CoV-2 antibodies was still below 5% during the 2nd wave of the pandemic. Antibodies remained present in the majority of baseline participants. Besides age and sex, potentially confounded by differences in behaviour, no major risk factors could be identified. Non-pharmaceutical public health measures are thus still important.

Competing Interest Statement

This study was funded by the Bavarian State Ministry of Science and the Arts, the University Hospital of Ludwig-Maximilians-University Munich, the Helmholtz Centre Munich, the University of Bonn, the University of Bielefeld, the European Unions Horizon 2020 research and innovation programme (ORCHESTRA Grant agreement ID: 101016167), Munich Center of Health (McHealth), the Deutsche Forschungsgesellschaft (SEPAN Grant number: HA 7376/3-1), Volkswagenstiftung (E2 Grant number: 99 450) and the German Ministry for Education and Research (MoKoCo19, reference number 01KI20271). Euroimmun, Mikrogen, Roche, and Viramed provided kits and machines for analyses at discounted rates. In addition, DM and VT are sub-investigators vaccines trials sponsored by Curevac AG. LO received non-financial support from Dr. Box Betrobox and grants from the Bavarian State Ministry of Science and the Arts during the conduct of the study. CR received royalities from Elsevier LTD for the textbook Clinical Cases in Tropical Medicine. She also received honoraria for lectures done at non-private academic institutions. CR is also chair of the Travel medicine board of the of the German Society for the Tropical Medicine, Travel Medicine and global health (unpaid) and member of the permanent committee on vaccinations at the Robert-Koch-Institute work group on travel vaccinations (unpaid). AW is on Roche Diagnostics and Roche Pharma Advisory Boards related SARS-CoV-2. The Bundeswehr Institute of Microbiology (RW) received research funding from the Medical Biodefence program of the Bundeswehr. The funders had no role in study design, data collection, data analyses, data interpretation, writing, or submission of this manuscript.

Funding Statement

This study was funded by the Bavarian State Ministry of Science and the Arts, the University Hospital of Ludwig-Maximilians-University Munich, the Helmholtz Centre Munich, the University of Bonn, the University of Bielefeld, the European Unions Horizon 2020 research and innovation programme (ORCHESTRA Grant agreement ID: 101016167), Munich Center of Health (McHealth), the Deutsche Forschungsgesellschaft (SEPAN Grant number: HA 7376/3-1), Volkswagenstiftung (E2 Grant number: 99 450) and the German Ministry for Education and Research (MoKoCo19, reference number 01KI20271). Euroimmun, Mikrogen, Roche, and Viramed provided kits and machines for analyses at discounted rates. The funders had no role in study design, data collection, data analyses, data interpretation, writing, or submission of this manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was conducted in accordance with good clinical (GCP) and epidemiological practice (GEP) standards as well as the Declaration of Helsinki in its most recent form (as amended by the 64th WMA General Assembly, Fortaleza, Brazil, in October 2013). The study protocol was approved by the Institutional Review Board of the Medical Faculty at Ludwig Maximilian University Munich, Germany (opinion dated 31 March 2020; number 20-275; opinion date amendment (follow-up): 10 October 2020), prior to study initiation.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data are accessible subject to data protection regulations upon reasonable request to the corresponding author. To facilitate reproducibility and reuse, the analysis and figure generation code has been made available on GitHub (https://github.com/koco19/epi2) and has been uploaded to ZENODO (https://doi.org/10.5281/zenodo.4707037) for long-term storage.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted April 29, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
From first to second wave: follow-up of the prospective Covid-19 cohort (KoCo19) in Munich (Germany)
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
From first to second wave: follow-up of the prospective Covid-19 cohort (KoCo19) in Munich (Germany)
Katja Radon, Abhishek Bakuli, Peter Pütz, Ronan Le Gleut, Jessica Michelle Guggenbuehl Noller, Laura Olbrich, Elmar Saathoff, Mercè Garí, Yannik Schälte, Turid Frahnow, Roman Wölfel, Michael Pritsch, Camilla Rothe, Michel Pletschette, Raquel Rubio-Acero, Jessica Beyerl, Dafni Metaxa, Felix Forster, Verena Thiel, Noemi Castelletti, Friedrich Rieß, Maximilian N. Diefenbach, Günter Fröschl, Jan Bruger, Simon Winter, Jonathan Frese, Kerstin Puchinger, Isabel Brand, Inge Kroidl, Andreas Wieser, Michael Hoelscher, Jan Hasenauer, Christiane Fuchs
medRxiv 2021.04.27.21256133; doi: https://doi.org/10.1101/2021.04.27.21256133
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
From first to second wave: follow-up of the prospective Covid-19 cohort (KoCo19) in Munich (Germany)
Katja Radon, Abhishek Bakuli, Peter Pütz, Ronan Le Gleut, Jessica Michelle Guggenbuehl Noller, Laura Olbrich, Elmar Saathoff, Mercè Garí, Yannik Schälte, Turid Frahnow, Roman Wölfel, Michael Pritsch, Camilla Rothe, Michel Pletschette, Raquel Rubio-Acero, Jessica Beyerl, Dafni Metaxa, Felix Forster, Verena Thiel, Noemi Castelletti, Friedrich Rieß, Maximilian N. Diefenbach, Günter Fröschl, Jan Bruger, Simon Winter, Jonathan Frese, Kerstin Puchinger, Isabel Brand, Inge Kroidl, Andreas Wieser, Michael Hoelscher, Jan Hasenauer, Christiane Fuchs
medRxiv 2021.04.27.21256133; doi: https://doi.org/10.1101/2021.04.27.21256133

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (240)
  • Allergy and Immunology (521)
  • Anesthesia (125)
  • Cardiovascular Medicine (1420)
  • Dentistry and Oral Medicine (217)
  • Dermatology (158)
  • Emergency Medicine (291)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (584)
  • Epidemiology (10297)
  • Forensic Medicine (6)
  • Gastroenterology (527)
  • Genetic and Genomic Medicine (2629)
  • Geriatric Medicine (254)
  • Health Economics (497)
  • Health Informatics (1733)
  • Health Policy (789)
  • Health Systems and Quality Improvement (673)
  • Hematology (266)
  • HIV/AIDS (565)
  • Infectious Diseases (except HIV/AIDS) (12093)
  • Intensive Care and Critical Care Medicine (649)
  • Medical Education (273)
  • Medical Ethics (83)
  • Nephrology (289)
  • Neurology (2461)
  • Nursing (145)
  • Nutrition (377)
  • Obstetrics and Gynecology (493)
  • Occupational and Environmental Health (568)
  • Oncology (1324)
  • Ophthalmology (401)
  • Orthopedics (146)
  • Otolaryngology (237)
  • Pain Medicine (168)
  • Palliative Medicine (51)
  • Pathology (343)
  • Pediatrics (780)
  • Pharmacology and Therapeutics (330)
  • Primary Care Research (296)
  • Psychiatry and Clinical Psychology (2397)
  • Public and Global Health (5007)
  • Radiology and Imaging (893)
  • Rehabilitation Medicine and Physical Therapy (528)
  • Respiratory Medicine (681)
  • Rheumatology (309)
  • Sexual and Reproductive Health (256)
  • Sports Medicine (245)
  • Surgery (298)
  • Toxicology (45)
  • Transplantation (140)
  • Urology (108)